Drug approvals - Page 5 of 65 - Express Pharma

FDA approves gene therapy to treat adults with Metastatic Synovial Sarcoma

Alembic Pharmaceuticals announces USFDA final approval for Nelarabine injection, 250 mg/50 mL (5 mg/mL) (Single-Dose Vial)

Axxelent receives its first US FDA Establishment Inspection Report (EIR)

Lupin secures tentative U.S. FDA approval for generic HIV treatment under PEPFAR

FDA approves Guardant Health’s Shield blood test as first primary CRC screening option

Successful completion of USFDA inspection at Alembic Pharma Oral Solid Formulation Facility (F-I) at Panelav

NovaLead’s patented repurposed drug gets CDSCO nod for DFU patients in India

Eisai and Biogen’s Leqembi launch in China marks turning point in Alzheimer’s treatment, says GlobalData

Oral JAK inhibitor LEQSELVI (deuruxolitinib) approved by US FDA for severe alopecia areata treatment

Pfizer’s gene therapy for Haemophilia A receives positive topline results from Phase 3 Study